Nachrichten zur Eli Lilly & Co Aktie

Eli Lilly, Novo Nordisks Historic GLP-1 Pricing Deals - What Investors Need To Know

…

Hims & Hers falls after Novo, Lilly strike deal with White House for weight-loss drugs

** Shares of telehealth firm Hims & Hers NYSE:HIMS fall 1.1% to $41.1 premarket** U.S. President Donald Trump, Eli Lilly…

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

The deals are among the most politically significant announcements to date in the Trump administrations efforts to rein in high…

Heres how much weight loss drugs could cost you under Trumps deals with Eli Lilly, Novo Nordisk

The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage…

TrumpRx GLP-1 pricing ‘less bad than feared’ for Hims & Hers, says Citi

Citi notes that the Trump administration announced that Eli Lilly (LLY) and Novo Nordisk (NVO) have agreed to significantly lower…

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study

The highest dose of Eli Lillys weekly injection helped patients with obesity or who are overweight lose 20.1% of their…

Novo, Lilly shares rise as Trump obesity drug deal nears

Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal…

Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports By Reuters

Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports…

Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports

U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo Nordisk…

Wall Street gets another reason to like Eli Lilly stock, and DuPonts spin is going to plan

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints News reports

Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight…

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies…

Is Eli Lilly a Millionaire Maker?

Eli Lilly has a leading position in a hot new drug category, but theres one notable problem to consider.…

Lilly Endowment sells $260m in Eli Lilly shares By Investing.com

Lilly Endowment sells $260m in Eli Lilly shares…

Tech rules Mondays stock market — plus, Eli Lillys big comeback and new vote of confidence

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Zweites Alzheimer-Medikament in Deutschland erhältlich

BERLIN (dpa-AFX) - Das Alzheimer-Medikament Donanemab (Handelsname Kisunla) ist ab sofort in Deutschland verfügbar. Nur wenige…

US-Pharmakonzern Eli Lilly plant Werk für 3 Milliarden Euro in den Niederlanden

INDIANAPOLIS/KATWIJK (dpa-AFX) - Der US-Pharmakonzern Lilly stockt seine Kapazitäten in Europa auf. Lilly plant den…

Lilly to build $3 billion Dutch plant to boost weight-loss pill production

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand…

Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus

…

Eli Lilly: The Price Upside Just Increased

…

Were raising our Eli Lilly price target — what a difference a quarter makes

The drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications…

Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a…

Stocks making the biggest moves premarket: Alphabet, Microsoft, Meta Platforms, Eli Lilly, Merck & more

These are some of the stocks posting the largest moves in early trading.…

Eli Lilly raises forecasts on surging demand for weight-loss drugs

Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong appetite for its widely popular weight-loss and…

Eli Lilly Q3 earnings and revenue top estimates, boosted by weight loss drug demand

Eli Lilly and Co (NYSE:LLY) on Thursday reported third quarter 2025 financial results that handily beat Wall Street forecasts, as the company…

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailers locations or…

In Lilly vs Novo obesity drug battle, Trump price talks grab focus

As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are…

Eli Lilly bereitet Milliarden Dosen neuer Abnehmpille vor

Eli Lilly steht kurz vor einem der größten Produktstarts seiner Geschichte. Der Pharmakonzern aus Indianapolis hat bereits Milliarden Dosen seiner…

How Omvoh’s FDA Approval at Eli Lilly (LLY) Has Changed Its Investment Story

On October 27, 2025, Eli Lilly announced that the U.S. FDA approved a new, once-monthly single-injection maintenance regimen of Omvoh…

Eli Lilly is stockpiling its weight loss pill, plus Nvidia reveals (many) new partners

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development

Its the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten…

Lilly partners with Nvidia on AI supercomputer to speed up drug development

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and…

Down 15%, Should You Buy the Dip on Eli Lilly?

Lillys stock has pulled back from its 2024 highs, but that doesnt mean the shares are cheap enough to buy.…

Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings

Eli Lillys Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure…

Should You Buy Eli Lilly Stock Before Oct. 30?

Long-term investors dont need to rush to buy Eli Lilly stock.…

Eli Lilly: Is Another Monster Quarter Coming

…

Key deals this week: United States Antimony, Grindr, Eli Lilly, Hologic and more

…

Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager

Key PointsSold 6,430 shares of Eli Lilly and Company; estimated transaction value ~$4.78 millionPost-trade holding: 61,292 shares valued at $46.77…

3 Things Investors Need to Know Ahead of Eli Lillys Q3 Earnings Report

The rapid growth rates of recent years arent guaranteed to continue.…

Eli Lilly Q3 earnings eyed for insights into drug pricing policies

Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…

Eli Lilly Q3 earnings eyed for insights into drug pricing policies, obesity and diabetes drug performance

Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…

Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing

Key PointsIncreased position by 259,392 shares in Q3 2025; estimated $193.03 million trade based on the average price during Q3…

Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price

Novo Nordisk and Eli Lilly shares fell after President Donald Trump said the price of the blockbuster diabetes drug Ozempic could come down to just…

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s

Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.…

Why Eli Lilly (LLY) Stock Is Down Today

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty…

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs

Trumps pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility…

Trump says Ozempic will get cheaper. Novo Nordisk, Eli Lilly stock slump

Trump’s comments on Ozempic “signal aggressive posturing” in drug price negotiations, an analyst said…

American Express, Truist Financial and Fifth Third rise premarket; Eli Lilly falls By Investing.com

American Express, Truist Financial and Fifth Third rise premarket; Eli Lilly falls…

Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback By Investing.com

Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback…

Treasuries Rally Amid Credit Woes; Trump to Meet Zelenskiy, Putin | Bloomberg Brief 10/17/2025

US equity futures decline, Treasuries extend rally and the dollar stays on track for its biggest weekly drop since July.…